Echo IQECHQF -19.49%13 3-Year ROIIC % is 231.08 as of Jun. 2025, which is 599% above its 10-year median of 33.08. GuruFocus rates ECHQF with a GF Score™ of 13/100 and a GF Value™ of $0.02 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 619 Healthcare Providers & Services companies, Echo IQ ranks better than 94.51% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Echo IQ's 3-Year ROIIC % for the quarter that ended in Jun. 2025 was 231.08%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Echo IQ's 3-Year ROIIC % or its related term are showing as below:
ECHQF's 3-Year ROIIC % is ranked better than 94.51% of 619
companies
in the Healthcare Providers & Services industry
Industry Median: 3.28
vs ECHQF: 231.08
Echo IQ (OTCPK:ECHQF) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Echo IQ 3-Year ROIIC % Related Terms
Echo IQ 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Echo IQ's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ECHQF vs VEEV, BTSG, TEM: 3-Year ROIIC % Comparison
For the Health Information Services subindustry, Echo IQ's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Echo IQ 3-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Echo IQ's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Echo IQ's 3-Year ROIIC % falls into.
Echo IQ's 3-Year ROIIC % for the quarter that ended in Jun. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( -8.924 (Jun. 2025) - -4.393 (Jun. 2022) )
/
( 3.22 (Jun. 2025) - 5.744 (Jun. 2022) )
=
-4.531
/
-2.524
=
179.52%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Echo IQ (ECHQF) has a 3-Year ROIIC % of 231.08 as of Jun. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Echo IQ and its competitors. This is 599% above median its historical median of 33.08. According to the industry distribution chart, Echo IQ ranks #34 out of 619 companies in the Healthcare Providers & Services industry, placing it in the top 5.5%.
Is Echo IQ's 3-Year ROIIC % too high?
Echo IQ's current 3-Year ROIIC % of 231.08 is 599% above median its 10-year median of 33.08. The Healthcare Providers & Services industry median 3-Year ROIIC % is 3.28. Echo IQ's value of 231.08 is 6945.1% above this industry median. Based on the distribution chart, Echo IQ ranks #34 out of 619 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Echo IQ has a GF Score™ of 13/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Echo IQ's 3-Year ROIIC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Echo IQ ranks #34 out of 619 companies for 3-Year ROIIC %. This places Echo IQ in the top 6% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 3.28. Echo IQ's value of 231.08 is 6945.1% above this benchmark. While the company's 10-year median is 33.08 vs. the industry median of 3.28, Echo IQ has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Healthcare Providers & Services company?
The median 3-Year ROIIC % among Healthcare Providers & Services companies is 3.28, based on 619 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Echo IQ's current 3-Year ROIIC % of 231.08 is 6945.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Echo IQ and its competitors. For the Healthcare Providers & Services industry, the median 3-Year ROIIC % is 3.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Echo IQ's current 3-Year ROIIC % is 231.08, which is 599% above median its own 10-year median of 33.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Echo IQ stock overvalued right now?
Based on GuruFocus' analysis, Echo IQ (ECHQF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.02, compared to a current price of $1.26 — trading 6220% above its estimated fair value. The current 3-Year ROIIC % is 231.08, which is 599% above median its 10-year median of 33.08 and 6945.1% above the Healthcare Providers & Services industry median of 3.28. Echo IQ's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Echo IQ (ECHQF), the current 3-Year ROIIC % is 231.08 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Echo IQ (ECHQF) Overvalued in 2026?
Based on GuruFocus' analysis, Echo IQ stock appears to be overvalued.
The current stock price of $1.26 is trading 6220% above its estimated GF Value™ of $0.02.
GuruFocus considers Echo IQ to be Significantly Overvalued.
Key valuation signals for ECHQF:
3-Year ROIIC %: 231.08 (599% above median its 10-year median of 33.08)
GF Value™: $0.02 vs. price of $1.26 (6220% above fair value)
Industry Position: 6945.1% above the Healthcare Providers & Services median (#34 of 619)
No single metric tells the full story. See the ECHQF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Echo IQ Ltd is an Australian medical technology company focused on improving decision-making in cardiology. Its proprietary EchoSolv platform leverages AI-driven analysis of echocardiographic data to help clinicians detect Aortic Stenosis (AS) and other conditions with greater accuracy and efficiency. The company is focused on expanding its strategic partnerships, progressing regulatory pathways, and completing successful deployments of its technology in the USA healthcare market to establish its position in AI-enabled cardiovascular care.
13GF Score
Get the complete analysis for ECHQF
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ECHQF has been successfully added to your 
